The Sean Spicer Show

Is the FDA BLOCKING Life Saving Cancer Treatments? | Ep 631

Jan 19, 2026
Dr. Patrick Soon-Shiong is a leading transplant surgeon and biotech entrepreneur focused on revolutionizing cancer treatment. He discusses how chemotherapy weakens the immune system, showcasing his groundbreaking therapy, Anktiva, which activates Natural Killer cells to combat cancer effectively. With Saudi Arabia approving Anktiva, he highlights the FDA's slow response, raising concerns about medical tourism for Americans. He also emphasizes the vital role of immune health and shares data proving Anktiva's success over traditional treatments.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

NK Cells And IL-15 Are Cancer Gamechangers

  • Natural killer (NK) cells and IL-15 are central to the immune response against cancer and were identified as crucial by the NCI.
  • Activating NK cells instead of only killing tumors could change cancer treatment paradigms.
ANECDOTE

Handshake Turned Policy Conversation

  • Dr. Patrick Soon-Shiong describes a prolonged handshake moment with President Trump that turned into a substantive discussion.
  • That interaction led to White House invitations and follow-up meetings about the BioShield program.
INSIGHT

FDA Bureaucracy Delayed Filings

  • Dr. Patrick Soon-Shiong reports repeated meetings with FDA reviewers and senior White House staff but says the FDA later 'refused to file' his submission without clear explanation.
  • He frames this as bureaucratic obstruction delaying patient access despite earlier encouragement to file.
Get the Snipd Podcast app to discover more snips from this episode
Get the app